26+ million shares traded on Friday, without news, and a pending R/S, is just a little too unusual.
I agree with your assessment. My purely speculative prognostication puts the stock price between .86 cents and $1.26 next week. There have been plenty of false starts (pump and dumps) in the past but Friday's volume tells me the current price action could be different. I think the most likely cause of the recent run up is an impending partnership regarding the exosome diagnostic cancer detection blood test for which I expect news sooner rather than later. If a partnership announcement is close, the company would have stopped using the ATM which could help explain the recent price appreciation. If "pros" have sussed out the company is no longer using the ATM, they would speculate about news that would end the need for ATM capital raises and would start loading the boat for the big runs to come. Past experience has made it so that nothing would surprise me with this company/stock but I have not felt this optimistic since before the phase 3 trial results came out. I have banked six figures of losses, repurchased my shares and, like many longs here, have a ways to go before getting close to break even but I am beginning to see a distant faint light at the end of the tunnel. Color me excited for Tuesday and GLTA fellow longs Rocker
Market Data 
Markets 
AI
